Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.

Hee Jeong LeeHaekyung LeeSong Hee OhJoonbyung ParkSuyeon ParkJin Seok JeonHyunJin NohDong Cheol HanSoon Hyo Kwon

Published in: PloS one (2018)

Chronic kidney disease patients are taking proton pump inhibitors for a much longer duration compared to non-chronic kidney disease patients. Physicians should pay careful attention when prescribing proton pump inhibitors to high risk groups.

Keyphrases

chronic kidney disease
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
primary care
emergency department
patient reported outcomes
small molecule
electronic health record
drug induced
adverse drug